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Abstract
Background—The prevalence of angina from 1971 to 1994 was relatively flat for whites and 
blacks. We ask whether the prevalence and medical history of angina have changed during 1988 to 
2012.
Methods and Results—We used the National Health and Nutrition Examination Survey data 
from 1988 to 2004 and the data from the six 2-year surveys from 2001 to 2012. We calculated 
trends in both crude and standardized prevalence rates for the Rose questionnaire on angina 
(symptomatology) and a question asking whether the respondent had ever been told by a medical 
professional that they had angina (medical history). In 2009 to 2012, there were on average 3.4 
million (95% confidence interval, 2.8–4.0 million) people aged ≥40 years in the United States 
each year with angina (Rose questionnaire) and 4.5 million (95% confidence interval, 3.5–5.1 
million) people with a medical history of angina. The burden of angina varied across age, race, 
and sex categories, and the pattern of variation differed by whether symptomatology or medical 
history was assessed. Statistically significant declines in the rates for both outcomes were noted, 
for the most part, in people aged ≥65 years. Age and sex standardized rates declined significantly 
for whites but not for blacks.
Conclusions—Rates of angina symptoms and medical history of angina have declined among 
non-Hispanic whites and among adults aged ≥65 years. Blacks have not experienced these same 
declines. Clearly, additional study is required to understand these declines and to track the future 
cost and burden of angina in the US population.
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Recent data that formally test the presence of secular changes in the prevalence of angina are 
lacking for the United States. Most epidemiological surveillance of angina has focused on 
hospitalization, emergency room, and outpatient visit data. Visit rates have declined in all 3 
of these settings1–5 Based on observing increasing rates of hospitalization for coronary 
atherosclerosis and increased use of coronary angiography from 1992 to 1999, ≥1 researcher 
has suggested that declines in angina hospitalization rates reflect trends in more aggressive 
diagnosis of coronary atherosclerosis, which has led to angina being replaced with a 
different discharge diagnosis.1
It is not clear whether the prevalence of angina (as distinguished from the visit rates for 
angina) has also been declining, which might help explain the drop in inpatient and 
outpatient visit rates found in recent studies. However, because the most recent study that 
formally tested for secular trends in angina prevalence was published >10 years ago,6 it 
sheds little light on this relatively recent phenomenon. In fact, the prevalence of angina from 
1971 to 1994 was relatively flat for whites and blacks, and the rate for Mexican Americans 
actually increased from 1982 to1994.6
The purpose of this study is to describe the population of people who self-reported angina 
using the Rose questionnaire and who self-reported a medical history of angina, to provide 
up-to-date findings related to secular trends in rates of these 2 outcomes, and to describe 
these trends by race.
Methods
Data Source and Definitions
We obtained population-based data from the National Health and Nutrition Examination 
Surveys (NHANES) that included data from 1988 to 2004 (NHANES III) and the 2-year 
surveys from 2001 to 2002, 2003 to 2004, 2005 to 2006, 2007 to 2008, 2009 to 2010, and 
2011 to 2012.7 We did not include the 1999 to 2000 survey because it was missing key 
information on angina for our analysis. All surveys were conducted by the National Center 
for Health Statistics and includes both an interview and an examination component.7 All 
research activities related to the surveys were reviewed and approved by the National Center 
for Health Statistics Research Ethics Review Board in accordance with 45 Code of Federal 
Regulations 46. NHANES are stratified probability-designed surveys. NHANES are 
complex, multistage stratified clustered sample surveys of the civilian, noninstitutionalized 
population for the purpose of assessing the health and nutrition status of the population aged 
≥2 months. NHANES have 4 stages of sampling. At the first stage of sampling, primary 
sampling units are selected that consist of counties or groups of counties. At the second 
stage, segments (blocks or groups of blocks) are selected within primary sampling units. The 
third stage consists of households within segments, and the final stage involves selecting ≥1 
participants within each household.
Based on data from NHANES III and the 5 surveys that were administered from 2001 
through 2010, response rates ranged from 78% to 84% for the interview and 73% to 80% for 
the examination. A surveyed individual can be considered a nonrespondent to either the 
NHANES interview or the NHANES examination. A person is considered a nonrespondent 
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to the interview if he/she was selected to be in the sample but did not agree to be 
interviewed. An individual who completes the interview but not the examination is 
considered a nonrespondent to the examination. Responders tend to be younger than 
nonresponders and vary in other ways. However, we used the weighted data that adjust for 
survey nonresponse. By using the weighted data, we are using analytic tools to ensure that 
our results represent the total sampled population (ie, the civilian noninstitutionalized US 
population).
The presence of angina was defined using 2 methods. First, we considered anyone 
answering yes to the question “Has a doctor or other health professional ever told {you/SP} 
that {you/s/he}…had angina, also called angina pectoris?” to be a person with a medical 
history of an angina diagnosis. Those who said no were considered to not have a medical 
history of a diagnosis of angina. Respondents who refused or did not answer the question or 
said they did not know (<1% overall, with a range from 0.22% to 0.47% depending on the 
time period) were eliminated from the calculation of angina prevalence rates. This question 
was part of the Medical Conditions Questionnaire that was administered to all sampled 
people or their proxy respondent in NHANES III and all later surveys. The question 
measures the lifetime medical history of angina and does not measure only recent history 
(eg, the previous year or the past 5 years). Second, we used the Rose questionnaire8,9 to 
determine which respondents have angina symptomatology, whether diagnosed or not. 
These questions were part of the Cardiovascular Disease Questionnaire that was 
administered to people aged ≥40 years in NHANES III and in all subsequent surveys, except 
for the 1999 to 2000 survey. The questions that were used and the scoring of the answers to 
the questions are presented in Appendix A in the Data Supplement. If a person failed to 
answer one of the questions (<1% overall, with a range from 0.14% to 0.34% depending on 
the time period), he/she was eliminated from the analysis. Because both methods are based 
on self-report and neither can be considered a gold standard, we treated them as independent 
estimates and did not combine them when calculating the prevalence of angina. Appendix B 
in the Data Supplement provides a cross-tabulation of the 2 measures and the resulting 
Cohen’s κ statistic of 0.15 that supports our decision to analyze the measures separately. To 
allow comparisons, we calculated prevalence rates using only the population aged ≥40 years 
because the Rose questionnaire was only administered to people in that age group.
In describing the characteristics of people with angina, we used 3 categories for race/
ethnicity: non-Hispanic white, non-Hispanic black, and other. Hispanics were included in 
the other category and could not be studied separately because of insufficient numbers 
leading to large SEs around the point estimates.
Statistical Analysis
Characteristics of Those With Angina, Angina Prevalence Rates, and Time 
Trends—We estimated the total weighted number of people aged ≥40 years with angina 
(using the 2 methods described above) in the United States by multiplying the crude 
prevalence of angina for people aged ≥40 years within each time period by population 
survey estimates for those aged ≥40 years in the United States.10 We calculated the 
prevalence over time; however, because angina is relatively rare (<5% of the population), 
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we need to combine surveys to obtain reliable estimates. We used NHANES III (1988–
1994) as is, but then combined 2 continuous surveys in the later years to obtain 3 additional 
time periods: 2001 to 2004, 2005 to 2008, and 2009 to 2012.
We first examined the demographic characteristics among people with angina defined by the 
2 methods. We stratified the population with angina by age (40–64 years and ≥65 years), 
sex, and race/ethnicity (as defined above) and then calculated the percentage of people in 
each stratum for each of the time periods. We used only 2 age strata because using more 
resulted in large SEs around the percentages. Second, we calculated the crude percentages of 
the US population with angina (again, using both methods for defining angina) by the same 
categories described above. Finally, we calculated the age- and sex-standardized percentages 
of people with angina in the United States—we did this for the total US population aged ≥40 
years and within racial categories using the 2000 US Census population11 as the standard. 
We calculated the standardized percentages across time so that we could assess whether 
there was a secular trend in the percentages.
Because of the complex sampling design, we used Survey Data Analysis12 to calculate 95% 
confidence intervals (CIs) around the estimates. We tested differences between subgroups 
using t tests, with α=0.05 as a measure of statistical significance; however, this testing was 
only performed for estimates that were considered reliable according to National Center for 
Health Statistics standards (ie, estimates based on ≥30 visits and those where the relative SE 
is ≤30%). We used the ANOVA-type Cochran–Mantel–Haenszel test in Survey Data 
Analysis to test for trend in each study subgroup.12
Results
Population Distribution of Angina
Symptomatology From the Rose Questionnaire—In 1988 to 1994, an average of 4 
million (95% CI, 3.6–4.6 million) people aged ≥40 years in the United States reported 
symptoms of angina each year (Figure 1). Recent estimates from 2009 to 2012 indicate that 
the number of people reporting such symptoms in this same age category is 3.4 million 
(95% CI, 2.8–4.0 million) people each year.
In every time period, angina symptoms were more often reported by people aged 40 to 64 
years (from 60% to 72%) than by people aged ≥65 years (Table 1). Women were more 
likely than men to report angina symptoms (≈60% and 40%, respectively). Approximately 
80% of people with symptoms were white. However, by 2009 to 2012, this had dropped 
significantly to 59%.
Medical History of Angina—In 2001 to 2004, an average of 5.9 million (95% CI, 5.0–
7.2 million) people aged ≥40 years in the United States reported a medical history of angina 
each year (Figure 1). More recent estimates from 2009 to 2012 indicate that the number of 
people aged ≥40 years reporting such a history is 4.5 million (95% CI, 3.5–5.1 million) each 
year.
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A medical history of angina was reported more frequently by people aged ≥65 years; 
however, this difference between those aged 40 to 64 years and those aged ≥65 years was 
only significant in 2005 to 2008 (Table 2). Women and men were equally likely to have 
such a medical history. As expected, given the distribution of race in the US population, 
whites make up the vast majority of people with a medical history of angina (80%–85% 
depending on time period).
Age- and Sex-Stratified Prevalences
Symptomatology From the Rose Questionnaire—Crude prevalence rates for those 
aged 40 to 64 years ranged from 2% to 3% for men and 3% to 4% for women (Table 3). 
Neither men nor women in this age category showed statistically significant declines in 
angina symptomatology over time. Prevalence rates for those aged ≥65 years ranged from 
3% to 5% for men and 2% to 6% for women. However, among people in this age category, 
the decline in rates was significant from the first time period (1988–1994) to the most recent 
time period (2009–2012) for both men and women. The absolute rate for women aged ≥65 
years dropped in half during the study period.
Medical History of Angina—Crude prevalence rates of a medical history of angina for 
those aged 40 to 64 years ranged from 2% to 3% for men and women (Table 3). Neither men 
nor women in this age category showed statistically significant declines in having been told 
by a doctor that they have angina during the study period. Prevalence rates for those aged 
≥65 years ranged from 8% to 11% for men and 5% to 9% for women. However, among 
people in this age category, the decline in rates was significant from 2001 to 2004 through 
2009 to 2012 only for women. The rate for women declined from 9.4% in 2001 to 2004 to 
5.1% in 2009 to 2012.
Secular Trends
Symptomatology From the Rose Questionnaire—For non-Hispanic whites, a test of 
linear trend showed that age- and sex-standardized rates for angina symptomatology (Table 
4; Figure 2) declined in a statistically significant linear fashion (P<0.0001) from the first 
(1988–1994) to the final (2009–2012) period. During those years, the actual rate declined by 
≈50%, from 4.0% to 2.1%. The rates for non-Hispanic blacks remained relatively flat 
during the same time period (Table 4; Figure 2).
Medical History of Angina—For non-Hispanic whites, a test of linear trend showed that 
age- and sex-standardized rates for a medical history of angina (Table 4; Figure 3) declined 
in a statistically significant linear fashion (P<0.001) from 2001 to 2004 through 2009 to 
2012. During those years, the actual rate declined by about one third, from 5.2% to 3.4%. 
The rates for non-Hispanic blacks remained relatively flat during the same time period 
(Table 4; Figure 2).
Discussion
Our results address an important gap in the epidemiology of cardiovascular disease by 
showing that the prevalence of angina symptoms among US adults aged 40 to 64 years has 
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declined significantly among non-Hispanic whites and most adults aged ≥65 years during 
the past 2 decades. Unfortunately, the prevalence of such symptoms has stayed relatively flat 
for non-Hispanic blacks during this same time period. This same racial disparity is observed 
for medical history of angina: rates for whites declined during the past decade but rates for 
blacks remained flat.
The results of the present study are consistent with data showing a decline in the rates of 
hospitalizations and emergency department visits for angina from 1995 to 2010.4 In that 
study, rates of emergency department visits for angina declined significantly among patients 
aged ≥65 years, a finding that is consistent with the present study.
A decline in the prevalence of angina for non-Hispanic whites could be the result of a 
declining incidence of angina, increased mortality among patients with angina, a changing 
healthcare system that is less likely to diagnose angina and report to patients that they have 
angina, or a combination of these factors. There are no national data about trends in incident 
angina, and therefore other data may offer some insights. Trends in cardiovascular risk 
factors present a mixed picture. The prevalence of smoking and mean concentration of total 
cholesterol have declined.13–15 Furthermore, the prevalence of meeting 2008 physical 
activity recommendations has increased from 1998 to 2010.16 The prevalence of 
hypertension increased from 1988 to 1994 through 1999 to 2000 but has since remained 
stable.17,18 In addition, control of hyperlipidemia and hypertension has also improved.19 In 
contrast, the prevalence of obesity and diabetes mellitus has increased substantially.20–23 
Despite this, predicted 10-year cardiovascular risk has declined since 1988 to 1994.24,25 
Furthermore, regional studies have shown that incident coronary heart disease has 
declined.26–30 Although the trends of risk factors present inconclusive supportive evidence, 
the studies concerning incident coronary heart disease suggest the possibility that incident 
angina may have declined.
Little is known about mortality rates among people with angina pectoris. Mortality rates 
from coronary heart disease in the United States have declined precipitously since the late 
1960s.31 Thus, mortality among adults with angina pectoris could have conceivably declined 
as well, which would lead to more people living longer with angina. Such a scenario would 
run counter to our observation of a lowering prevalence of angina for whites. However, it 
could possibly explain why rates are not declining for blacks.
Another possible explanation for the relatively flat rates for blacks is that risk factors are not 
declining as much for blacks as for whites. This is supported by the results of a recent 
analysis of trends of 10-year predicted cardiovascular disease risk showing that risk has 
declined significantly for non-Hispanic whites but not for non-Hispanic Blacks.25 The more 
favorable trends in risk factor evolution among non-Hispanic whites than non-Hispanic 
Blacks—principally, systolic blood pressure, total cholesterol, and diabetes mellitus—likely 
influenced the divergent trajectories of prevalent angina.25 To jump start a decline in angina 
prevalence among non-Hispanic Blacks, underlying health disparities in cardiovascular risk 
factors will need to be addressed.
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Despite a growing population, the number of adults with angina has not increased, which 
indicates that the prevalence of angina has not kept up with the growth in the US population. 
These numbers have implications for the healthcare sector and suggest that fewer resources 
may be needed to treat angina in the future.
The results of this study are subject to several limitations. First, both angina 
symptomatology and medical history definitions were based on self-reported information 
and, consequently, are subject to error. In fact, a recent study showed that being black, 
having lower education, being women, and not having had a healthcare visit in the past year 
are associated with undiagnosed angina (ie, having symptoms but not having been told by a 
doctor that you have angina).32 The authors of the study suggest that these findings point to 
problems with awareness of disease and health communication issues for these subgroups of 
the population. Consequently, rates of medical history of angina may be underestimated for 
these groups. However, the validity and reliability of the Rose questionnaire have been 
evaluated and are generally thought to be reasonable.9 The questionnaire has been used 
widely in cardiovascular epidemiological studies, including in many countries, in various 
subpopulations and races, and in various educational and occupational groups.32 Second, the 
numbers of participants with angina were insufficient to allow examination by detailed 
demographic subgroups. Third, the numbers necessitated the aggregation of survey cycles to 
improve the stability of the estimates. Finally, the surveys did not include information 
allowing estimates on incident angina to be calculated.
In conclusion, both the prevalence rates of angina symptoms and the prevalence rates of the 
medical history of angina have declined among non-Hispanic whites and among adults aged 
≥65 years. Disturbingly, however, blacks have not experienced these declines in either 
outcome. This disparity needs to be addressed, most likely through the delivery of more 
intensive public health interventions aimed at addressing the cardiovascular needs of black 
Americans. The present study was unable to provide data to explain the possible reasons for 
the apparent decline in the prevalence of angina symptoms and medical history, and, 
therefore, studies that investigate possible contributing factors to these declines are needed. 
Continued surveillance efforts will be critical to monitoring the future course of the costs 
and burden of angina in the US population.
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• Hospitalizations, emergency department visits, and outpatient visits for angina 
have declined substantially since the late 1980s, and previous research suggests 
that physician behavior in response to changes in coding guidelines may have 
played an important role in explaining these declines.
• Another possible contribution to these decreasing visit rates is that the 
prevalence of angina may have declined since the late 1980s; however, the most 
recent analyses of secular trends of angina prevalence were conducted from 
1971 to 1994.
WHAT THE STUDY ADDS
• This epidemiological research, which spans from 1988 to 2012, shows that the 
prevalence of self-reported angina symptoms (as measured by the Rose 
questionnaire) has declined in people aged ≥65 years in the United States.
• Declines in the prevalence of both angina symptoms and medical history have 
declined for whites aged ≥40 years but not for their black counterparts.
• Although it is likely that early diagnosis and treatment of risk factors for angina 
may have played a role in these declines, more research is needed to confirm 
this, to better understand why racial disparities exist, and to develop appropriate 
strategies to reduce these disparities.
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Total population of people aged ≥40 years with angina symptoms or with a medical history 
of angina.
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Secular trends in age- and sex-standardized prevalence rates of angina for adults aged ≥40 
years in the United States, by race, for angina symptoms defined using the Rose 
questionnaire. Source: National Health and Nutrition Examination Surveys, 1988 to 2012. 
Note: The linear decline for whites is statistically significant at P<0.0001, and the vertical 
lines indicate 95% confidence intervals for each point estimate.
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Secular trends in age- and sex-standardized prevalence of a medical history of angina for 
adults aged ≥40 years in the United States, by race, for angina defined according to whether 
a doctor had ever told the respondent that they had angina. Source: National Health and 
Nutrition Examination Surveys, 1988 to 2012. Note: The declining linear trend for whites is 
statistically significant at P<0.01, and the vertical lines indicate 95% confidence intervals 
for the point estimates.
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Table 3
Age- and Sex-Stratified Percentage of People With Angina Symptoms or a Medical History of Angina and 
95% Confidence Intervals Among Those Aged ≥40 Years by Time Period: NHANES, 1988 to 2012 (United 
States)
NHANES III 2001–2004 2005–2008 2009–2012
Angina symptoms (Rose questionnaire)
 40–64 y
  Men 2.9 (2.1–4.1) 2.6 (1.7–3.8) 2.2 (1.6–2.9) 1.9 (1.3–2.7)
  Women 4.4 (3.5–5.6) 3.5 (2.7–4.6) 3.6 (2.8–4.5) 3.2 (2.4–4.1)
 ≥65 y
  Men 5.1 (4.1–6.2) 4.1 (2.9–5.9) 3.3 (2.2–4.9) 2.9 (2.1–4.0)*
  Women 5.6 (4.7–6.6) 4.6 (3.4–6.2) 4.6 (3.6–5.8) 2.4 (1.7–3.2)*
Medical history (doctor told them they had angina)
 40–64 y
  Men … 3.3 (2.3–4.8) 2.1 (1.5–2.8) 2.0 (1.3–3.2)
  Women … 2.6 (1.7–3.8) 2.0 (1.4–2.8) 2.0 (1.4–2.8)
 ≥65 y
  Men … 11.0 (9.5–12.8) 9.7 (7.2–13.0) 7.8 (5.8–10.4)
  Women … 9.4 (7.4–11.8) 6.3. (4.7–8.3) 5.1 (4.2–6.4)*
NHANES indicates National Health and Nutrition Examination Survey.
*
Rates dropped significantly (P<0.05) from the first time period to the last time period.
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Table 4
Age- and Sex-Standardized Rates of Angina and 95% Confidence Intervals Among Adults Aged ≥40 Years by 
Time Period: NHANES, 1988 to 2012 (United States)
Angina NHANES III 2001–2004 2005–2008 2009–2012
Angina symptoms (Rose questionnaire)
 Non-Hispanic White 4.0 (3.5–4.7) 3.3 (2.7–4.1) 3.0 (2.4–3.6) 2.1 (1.6–2.7)*
 Non-Hispanic Black 4.9 (4.1–5.9) 5.0 (3.7–6.9) 5.0 (4.1–6.0) 4.4 (3.6–5.4)
Medical history (doctor told them they had angina)
 Non-Hispanic White … 5.2 (4.4–6.3) 3.7 (3.0–4.5) 3.4 (2.7–4.2)†
 Non-Hispanic Black … 2.6 (1.9–3.4) 2.8 (2.1–3.8) 2.7 (1.9–3.8)
NHANES indicates National Health and Nutrition Examination Survey.
*
Percentages declined in a statistically significant linear fashion over time (P<0.0001).
†
Percentages declined in a statistically significant linear fashion over time (P<0.01).
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